Western blot and qRT‐PCR analyses revealed that the expression of E2F6 was positively associated with NF‐κB activation in GBM cells at the protein (Figure5a) and mRNA levels (Figure 5b). The gene discussed is NFKB1; the disease is glioblastoma.